TSCAN THERAPEUTICS, INC. (TCRX) Operating income 2020–2025
TSCAN THERAPEUTICS, INC. (TCRX) annual operating income history from SEC filings — each fiscal year as reported.
-$135.8MFY2025 · since FY2020: -$26.2M → -$135.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$135.8M | -0.7% |
| FY2024 | -$134.8M | -44.3% |
| FY2023 | -$93.5M | -40.3% |
| FY2022 | -$66.6M | -37.0% |
| FY2021 | -$48.6M | -85.4% |
| FY2020 | -$26.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice